Site-specific, Rep-mediated integration of the intact β-globin locus in the human erythroleukaemic cell line K562

Gene Therapy

Volumn 15, Issue 20, 2008, Pages 1372-1383

  Howden, S E ^a,b   Voullaire, L ^a   Wardan, H ^a   Williamson, R ^b   Vadolas, J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HELICASE; MESSENGER RNA; PARVOVIRUS VECTOR;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL STRAIN K 562; CHROMOSOME 19; CONTROLLED STUDY; DRUG SAFETY; DRUG SYNTHESIS; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; SOUTHERN BLOTTING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

BETA-GLOBINS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 19; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, REPORTER; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUTAGENESIS, SITE-DIRECTED; TRANSGENES; VIRAL PROTEINS;

ADENO-ASSOCIATED VIRUS; BACTERIA (MICROORGANISMS);

EID: 53649109805     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.84     Document Type: Article

References (45)

1. Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000; 105: 409-411.
2. Wilson C, Bellen HJ, Gehring WJ. Position effects on eukaryotic gene expression. Annu Rev Cell Biol 1990; 6: 679-714.
3. International Human Genome Mapping Consortium. A physical map of the human genome. Nature 2001; 409: 934-941.
4. Probst FJ, Fridell RA, Raphael Y, Saunders TL, Wang A, Liang Y et al Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 1998; 280: 1444-1447.
5. Yang XW, Wynder C, Doughty ML, Heintz N. BAC-mediated gene-dosage analysis reveals a role for Ziprol (Ru49/Zfp38) in progenitor cell proliferation in cerebellum and skin. Nat Genet 1999; 22: 327-335.
6. Wade-Martins R, White RE, Kimura H, Cook PR, James MR. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat Biotechnol 2000; 18: 1311-1314.
7. Bochukova EG, Jefferson A, Francis MJ, Monaco AP. Genomic studies of gene expression: Regulation of the Wilson disease gene. Genomics 2003; 81: 531-542.
8. Sarsero JP, Holloway TP, Voullaire L, Gazeas S, Fowler KJ, Kirby DM et al. Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice. Mamm Genome 2004; 15: 370-382.
9. Vadolas J, Wardan H, Bosmans M, Zaibak F, Jamsai D, Voullaire L et al Transgene copy number-dependent rescue of murine beta-globin knockout mice carrying a 183 kb human beta-globin BAC genomic fragment. Biochim Biophys Acta 2005; 1728: 150-162.
10. Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, Laughlin CA et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87: 2211-2215.
11. Kotin RM, Menninger JC, Ward DC, Berns KI. Mapping and direct visualization of a region specific viral DNA integration site on chromosome 19q13-qter. Genomics 1991; 10: 831-834.
12. Kotin RM, Linden RM, Berns KI. Characterization of a preferred site on chromosome19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 1992; 11: 5071-5078.
13. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991; 10: 3941-3950.
14. Hauswirth WW, Berns KI. Adeno-associated virus DNA replication: nonunit-length molecules. Virology 1979; 93: 57-68.
15. McLaughlin S, Collis KP, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: Analysis of proviral structures. J Virol 1988; 62: 1963-1973.
16. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
17. Owens RA, Weitzman MD, Kyostio SR, Carter BJ. Identification of a DNA-binding domain in the amino terminus of adenoassociated virus Rep proteins. J Virol 1993; 67: 997-1005.
18. Snyder RO, Im DS, Ni T, Xiao X, Samulski RJ, Muzyczka N. Features of the adeno-issociated virus origin involved in substrate recognition by the viral Rep protein. J Virol 1993; 67: 6096-6104.
19. Kyostio SR, Wonderling RS, Owens RA. Negative regulation of the adeno-associated virus (AAV) p5 promoter involves both the p5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol 1995; 69: 6787-6796.
20. Giraud C, Winocour E, Berns KI. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci USA 1994; 91: 10039-10043.
21. Weitzman MD, Kyostio SR, Kotin RM, Owens RA. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 1994; 91 5808-5812.
22. Linden RM, Ward P, Giraud C, Winocour E, Berns KI. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1996; 93: 11288-11294.
23. Linden RM, Winocour E, Berns KI. The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci USA 1996; 93: 7966-7972.
24. Urcelay E, Ward P, Wiener SM, Safer B, Kotin RM. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J Virol 1995; 69: 2038-2046.
25. Yang CC, Xiao X, Zhu X, Ansardi DC, Epstein ND, Frey MR et al. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J Virol 1997; 71: 9231-9247.
26. Balague C, Kalla M, Zhang WW. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol 1997; 71: 3299-3306.
27. Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K et al. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 1997; 71: 7951-7959.
28. Pieroni L, Fipaldini C, Monciotti A, Cimini D, Sgura A, Fattori E et al. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 1998; 249: 249-259.
29. Tsunoda H, Hayakawa T, Sakuragawa N, Koyama H. Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. Virology 2000; 268: 391-401.
30. Kogure K, Urabe M, Mizukami H, Kume A, Sato Y, Monahan J et al. Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components. Int J Hematol 2001; 73: 469-475.
31. Philpott NJ, Gomos J, Berns KI, Falck-Pedersen E. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci USA 2002; 99: 12381-12385.
32. Feng D, Chen J, Yue Y, Zhu H, Xue J, Jia WW. A 16 bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1. J Mol Biol 2006; 358: 39-45.
33. Yang Q, Chen F, Trempe JP. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol 1994; 68: 4847-4856.
34. Hermanns J, Schulze A, Jansen-Dblurr P, Kleinschmidt JA, Schmidt R, zur Hausen H. Infection of primary cells by adeno-associated virus type 2 results in modulation of cell cycle-regulating proteins. J Virol 1997; 71: 6020-6027.
35. Christian SL, Fantes JA, Mewborn SK, Huang B, Ledbetter DH. Large genomic duplicons map to sites of instability in the Prader_Willi/ Angelman syndrome chromosome region (15q11-q13). Hum Mol Genet 1999; 8: 1025-1037.
36. Benz EJ, Murnane MJ, Tonkonow BL, Berman BW, Mazur EM, Cavallesco C et al. Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci USA 1980; 77: 3509-3513.
37. Gambari R, Amelotti F, Piva R. Efficient cell proliferation and predominant accumulation of epsilonglobin mRNA in human leukemic K562 cells which produce mostly Hb Gower 1. Experientia 1985; 41: 673-675.
38. Howden SE, Voullaire L, Vadalos J. The transient expression of mRNA encoding for Rep protein facilitates targeted plasmid integration. J Gene Med 2008; 10: 42-50.
39. Vadalos J, Wardan H, Orford M, Voullaire L, Zaibak F, Williamson R et al. Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the b-globin locus in erthropoietic cells. Blood 2002; 100: 4209-4215.
40. Vadalos J, Wardan H, Orford M, Williamson R, Ioannou PA. Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin. Hum Mol Genet 2004; 13: 223-233.
41. Oehmig A, Cortés ML, Perry KF, Sena-Esteves M, Fraefel C, Breakefield XO. Integration of active human b-galactosidase gene (100 kb into genome using HSV/AAV amplicon vector. Gene Therapy 2007; 14: 1078-1091.
42. McCarty DM, Young SM, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004; 38: 819-845.
43. Narayanan K, Williamson R, Zhang Y, Stewart AF, Ioannou PA. Efficient and precise engineering of a 200 kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Therapy 1999; 6: 442-447.
44. Orford M, Nefedov M, Vadolas J, Zaibak F, Williamson R, Ioannou PA. Engineering EGFP reporter constructs into a 200 kb human beta-globin BAC clone using GET Recombination. Nucleic Acids Res 2000; 28: E84.
45. Blower MD, Sullivan BA, Karpen GH. Conserved organization of centromeric chromatin in flies and humans. Dev Cell 2002; 2: 319-330.